ISSN 0253-2778

CN 34-1054/N

Open AccessOpen Access JUSTC

Anticancer effect of Kean Cream in vivo and in vitro on mouse melanoma skin cancer via transdermal drug delivery

Cite this:
  • Received Date: 04 July 2008
  • Rev Recd Date: 12 November 2008
  • Publish Date: 30 April 2009
  • To investigate the anticancer effect of Kean Cream, in which realgar nanoparticles are the main ingredient, a transdermal drug delivery system was applied to tumor tissues to increase its bioavailability and decrease its toxicity. The results show that Kean Cream could significantly suppress the proliferation and induce apoptosis of B16 melanoma cells, both in a dose-dependent manner, and tests in vivo show that Kean Cream can decrease tumor volume markedly compared to the control. Furthermore, HE stain revealed that Kean Cream can inhibit angiogenesis. Meanwhile, Kean at this concentration has little side-effect on mice. These results suggest that Kean Cream is a potential efficient transdermal anticancer agent.
    To investigate the anticancer effect of Kean Cream, in which realgar nanoparticles are the main ingredient, a transdermal drug delivery system was applied to tumor tissues to increase its bioavailability and decrease its toxicity. The results show that Kean Cream could significantly suppress the proliferation and induce apoptosis of B16 melanoma cells, both in a dose-dependent manner, and tests in vivo show that Kean Cream can decrease tumor volume markedly compared to the control. Furthermore, HE stain revealed that Kean Cream can inhibit angiogenesis. Meanwhile, Kean at this concentration has little side-effect on mice. These results suggest that Kean Cream is a potential efficient transdermal anticancer agent.
  • loading
  • 加载中

Catalog

    Article Metrics

    Article views (214) PDF downloads(224)
    Proportional views

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return